Molecular determinants of autoimmunity and immune related adverse events in advanced cancer patients treated with immune checkpoint inhibitors (AUTO-CHECK study)
conference contribution
posted on 2018-11-01, 00:00authored byAnna K Nowak, Sonia Yip, Martin Stockler, Desmond Yip, Paul Mitchell, Yoland Antill, Daniel Andrews, Chee Lee, Craig Gedeye, Mustafa Khasraw, Kristy Robledo, Michelle Parry, Carola Vinuesa, Sayed Ali, Willem J Lesterhuis, Matthew Cook
Molecular determinants of autoimmunity and immune related adverse events in advanced cancer patients treated with immune checkpoint inhibitors (AUTO-CHECK study)